229 related articles for article (PubMed ID: 3926591)
1. Antisecretory and serum gastrin lowering effect of enprostil in patients with duodenal ulcer disease.
Mahachai V; Walker K; Sevelius H; Thomson AB
Gastroenterology; 1985 Sep; 89(3):555-61. PubMed ID: 3926591
[TBL] [Abstract][Full Text] [Related]
2. Comparative effects of two cimetidine regimens on 24-hour intragastric acidity in patients with asymptomatic duodenal ulcer.
Mahachai V; Walker K; Jamali F; Navert H; Cook D; Symes A; Thomson AB
Clin Ther; 1984; 6(3):259-81. PubMed ID: 6373006
[TBL] [Abstract][Full Text] [Related]
3. Enprostil, a synthetic prostaglandin E2 analogue, inhibits meal-stimulated gastric acid secretion and gastrin release in patients with duodenal ulcer.
Thomas FJ; Koss MA; Hogan DL; Isenberg JI
Am J Med; 1986 Aug; 81(2A):44-9. PubMed ID: 3092654
[TBL] [Abstract][Full Text] [Related]
4. Enprostil reduces G-cell hyperplasia and hypergastrinemia in duodenal ulcer.
Jewell LD; Yacoub W; Salkie ML; Sherbaniuk R; Walker K; Mahachai V; Kirdeikis P; Simpson I; Zuk L; Brunet MK
Clin Ther; 1987; 9(3):281-95. PubMed ID: 3111703
[TBL] [Abstract][Full Text] [Related]
5. [Efficacy and tolerability of enprostil in the treatment of duodenal ulcer. Comparison with cimetidine].
Frexinos J; Andrieu J; Evreux M; Guerre J; Michel H; Vicari F; Joubert M
Gastroenterol Clin Biol; 1989; 13(2):188-92. PubMed ID: 2496000
[TBL] [Abstract][Full Text] [Related]
6. Interrelationship between gastric acidity and gastrin concentration in patients with duodenal or gastric ulcer and in healthy subjects.
Mahachai V; Walker K; Pinchbeck B; Thomson AB
Clin Ther; 1985; 7(4):424-41. PubMed ID: 4016826
[TBL] [Abstract][Full Text] [Related]
7. Effect of combination of antacid and cimetidine on 24-hour intragastric acidity in patients with asymptomatic duodenal ulcer.
Mahachai V; Jamali F; Thomson AB
Clin Ther; 1984; 6(6):808-23. PubMed ID: 6391667
[TBL] [Abstract][Full Text] [Related]
8. Effect of two-week treatment with enprostil (35 micrograms twice a day) on 24-hour serum gastrin levels.
Florent C; Cogoni C; Joubert M; Desaint B
Dig Dis Sci; 1990 Nov; 35(11):1352-7. PubMed ID: 2121423
[TBL] [Abstract][Full Text] [Related]
9. Synergistic interaction between an H2-receptor antagonist and enprostil on 24-hour intragastric pH, serum gastrin concentration, and tissue immunoperoxidase staining for gastrin, somatostatin, and serotonin in a patient with metastatic gastrinoma.
Sherbaniuk R; Jewell LD; Yacoub W; Pinchbeck B; Salkie ML; Walker K; Mahachai V; Kirdeikis P; Zuk L; Brunet MK
Clin Ther; 1986; 8(6):667-88. PubMed ID: 2878726
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of enprostil against aspirin-induced gastroduodenal mucosal injury in man. Comparison with cimetidine and sucralfate.
Stiel D; Ellard KT; Hills LJ; Brooks PM
Am J Med; 1986 Aug; 81(2A):54-8. PubMed ID: 3092656
[TBL] [Abstract][Full Text] [Related]
11. Effect of enprostil, a synthetic prostaglandin E2 on 24 hour intragastric acidity, nocturnal acid and pepsin secretion.
Deakin M; Ramage J; Paul A; Gray SP; Billings J; Williams JG
Gut; 1986 Sep; 27(9):1054-7. PubMed ID: 3093317
[TBL] [Abstract][Full Text] [Related]
12. Enprostil. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of peptic ulcer disease.
Goa KL; Monk JP
Drugs; 1987 Nov; 34(5):539-59. PubMed ID: 3121276
[TBL] [Abstract][Full Text] [Related]
13. Comparative effects of pirenzepine and cimetidine, alone and in combination, on 24-hour gastric acidity in duodenal ulcer disease.
Mahachai V; Reilly P; Thomson AB
Clin Ther; 1984; 7(1):98-111. PubMed ID: 6394132
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of the gastric acid and serum gastrin-lowering effects of the prostaglandin E2 analog enprostil.
Baak LC; Jansen JB; Meijer JL; Lamers CB
Clin Pharmacol Ther; 1993 Jun; 53(6):668-4. PubMed ID: 8513659
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of prostanoids in the treatment of gastric ulcer.
Rachmilewitz D
Clin Invest Med; 1987 May; 10(3):238-42. PubMed ID: 3113800
[TBL] [Abstract][Full Text] [Related]
16. Treatment of duodenal ulcer with enprostil, a prostaglandin E2 analogue.
Bright-Asare P
Am J Med; 1986 Aug; 81(2A):64-8. PubMed ID: 3092658
[TBL] [Abstract][Full Text] [Related]
17. Comparison of cimetidine and ranitidine on 24-hour intragastric acidity and serum gastrin profile in patients with esophagitis.
Mahachai V; Walker K; Thomson AB; Zuk L; Kirdeikis P; Fisher D; Brunet K
Dig Dis Sci; 1985 Apr; 30(4):321-8. PubMed ID: 3979238
[TBL] [Abstract][Full Text] [Related]
18. Twenty-four-hour intragastric acidity and clinical trial of bedtime enprostil 70 micrograms compared with ranitidine 300 mg in duodenal ulcer.
Walt RP; Pounder RE; Hawkey CJ; Santana IA; Somerville KW; Logan RF; Long RG; Langman MJ
Aliment Pharmacol Ther; 1987 Apr; 1(2):161-6. PubMed ID: 2979218
[TBL] [Abstract][Full Text] [Related]
19. Enprostil and cimetidine: comparative efficacy and safety in patients with duodenal ulcer.
Carling L; Unge P; Almström C; Cronstedt J; Ekström P; Hägg S; Hansson B
Scand J Gastroenterol; 1987 Apr; 22(3):325-31. PubMed ID: 3109017
[TBL] [Abstract][Full Text] [Related]
20. Enprostil, a prostaglandin E2 analogue, in the treatment of duodenal ulcer; a multicentre comparison with cimetidine.
Jazrawi RP; Northfield TC; Reed PI; Cockel R; Schillers KF; Barkers ES
Aliment Pharmacol Ther; 1988 Aug; 2(4):353-9. PubMed ID: 2979259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
